The Current Ratio as of December 2025 (TTM) for Mabpharm Limited (2181.HK) is 1.07

According to Mabpharm Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.07. This represents a change of -2.44% compared to the average of 1.10 of the last 4 quarters.

Mabpharm Limited (2181.HK) Historical Current Ratio (quarterly & annually)

How has 2181.HK Current Ratio performed in the past?

The mean historical Current Ratio of Mabpharm Limited over the last ten years is 1.82. The current 1.07 Current Ratio has changed 5.78% with respect to the historical average. Over the past ten years (40 quarters), 2181.HK's Current Ratio was at its highest in in the June 2019 quarter at 4.59. The Current Ratio was at its lowest in in the January 2017 quarter at 0.

Mabpharm Limited (2181.HK) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Mabpharm Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Mabpharm Limited (2181.HK) Average Current Ratio

How has 2181.HK Current Ratio performed in the past?

The current Current Ratio of Mabpharm Limited (2181.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Mabpharm Limited (2181.HK) Current Ratio vs. Peers

How is 2181.HK’s Current Ratio compared to its peers?

Mabpharm Limited’s Current Ratio is greater than SinoMab BioScience Limited (0.87), less than HighTide Therapeutics Inc (3.44), less than Shanghai Bio-heart Biological Technology Co., Ltd. (12.65), less than Cutia Therapeutics (3.16), greater than Immunotech Biopharm Ltd (0.08), less than Frontage Holdings Corporation (1.24), less than JW (Cayman) Therapeutics Co. Ltd (1.59), less than Zhaoke Ophthalmology Limited (4.40), less than 3D Medicines Inc. (1.59), less than Genor Biopharma Holdings Limited (4.93),

Build a custom stock screener for Mabpharm Limited (2181.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Mabpharm Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Mabpharm Limited (2181.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Mabpharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.